NeuroOne Medical Technologies
NeuroOne Medical Technologies (OTCQB:NMTC) is developing high-definition, minimally invasive diagnostic and treatment devices based on our unique thin film electrode technology. Our initial focus is on epilepsy and the fast-growing neurostimulation device market.
President and CEO
NeuroOne Medical Technologies
Mr. Rosa is an entrepreneur with three decades of experience in the medical device industry spanning a variety of technologies and products. In addition to CEO roles with early-stage medical device companies, Mr. Rosa’s background also includes senior roles with C.R. Bard Inc., Boston Scientific Inc., and St. Jude Medical, where his responsibilities included marketing, product development and business development. He has been named as an inventor on multiple medical device patents, serves on seven corporate boards, and has raised $200M in the capital markets. Mr. Rosa holds an MBA from Duquesne University, and a BS in Commerce and Engineering from Drexel University.